Press Release

The Anticipated Introduction of Emerging Therapies by Pharma Giant Novartis is expected to boost the market for Graves’ Disease

5353 new20logo 01

Graves’-Disease-Market-Insights

DelveInsight’s Graves’ Disease Market Report offers a comprehensive understanding of Graves’ Disease, historical and forecasted epidemiology, and Graves’ Disease market patterns in the  7MM (United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan).

Some of the Important Findings from the Graves’ Disease Market Report

  • According to Wemeau et al. (2018), 73.3 percent of 1,572 hyperthyroid patients in France had Graves’ Disease (primary or recurrence), with 85 percent of them being female.
  • According to Minamitani et al. (2017), Graves’ Disease is responsible for the majority of childhood hyperthyroidism cases. Pediatric patients account for fewer than 5% of all Graves’ Disease patients, with a prevalence of 0.02 percent.
  • In the United Kingdom, autoimmune hyperthyroidism (Graves’ Disease) is the most prevalent type, accounting for 60 to 80 percent of cases, according to the National Institute for Health and Care Excellence (NICE) (2019).
  • Iscalimab (Novartis) and Secukinumab (Novartis) are the pipeline therapies in the Graves’ Disease Market.
  • Novartis is among the key pharmaceutical companies which are currently active in the Graves’ Disease Market.
  • The rise in Graves’ Disease market size is a direct result of the increase in 7MM cases. The Graves’ Disease therapeutic market is expected to expand due to improved disease understanding and advancements in therapeutic management.

Request Sample @ Graves’ Disease Market Insights

The Graves’ Disease market report covers existing clinical trends, new drugs, Graves’ Disease market share of individual therapies, and current and forecasted Graves’ Disease market size from 2018 to 2030 segmented by seven major markets.

Graves’ Disease: Overview

Graves’ Disease is a form of hyperthyroidism that affects many people. Thyroid-stimulating immunoglobulins are antibodies produced by the immune system in this autoimmune disorder. They then bind to healthy thyroid cells, triggering an overproduction of thyroid hormone in the body.

Thyroid hormones have an effect on the nervous system, brain growth, body temperature, and other vital aspects. It induces weight loss, anxiety, jitteriness, irritability, depression, and mental or physical exhaustion if left untreated. Other risks include vision issues, heart problems, skin problems, and so on.

Graves’ Disease Epidemiology Segmentation

  • Graves’ Disease Total Prevalence
  • Graves’ Disease Gender-Specific Cases
  • Graves’ Disease Age-Specific Cases

Know more about epidemiology @ Graves’ Disease Causes, Treatment and Epidemiology

Graves’ Disease Treatment Landscape

For people with Graves’ Disease, there are three treatment options: medication, radioiodine therapy, and thyroid surgery. In the United States, radioiodine therapy remains the most popular treatment for Graves’ Disease, although physicians are starting to use medicine more often than in the past.

The best care for the patient is determined by the patient’s age, pregnancy, and the involvement of other medical conditions.

Graves’ Disease Market

Owing to a rise in the number of cases, as well as a better understanding of the disease and new therapies such as Iscalimab (Novartis) and Secukinumab (Novartis), the Graves’ Disease market size is expected to expand during the forecast period (2021-2030).

Graves’ Disease Pipeline Therapies and Key Companies

  • Iscalimab: Novartis
  • Secukinumab: Novartis

Get more insights about emerging drugs @ Graves’ Disease Emerging Therapies and Major Players

Table of Contents

1. Key Insights
2. Graves’ Disease : Market Overview at a Glance
3. Executive Summary
4. Organizations
5. Graves’ Disease Patient Journey
6. Disease Overview: Graves’ Disease
7. Graves’ Disease Epidemiology and Patient Population
8. Graves’ Disease Case studies
9. Graves’ Disease Emerging Therapies
10. Graves’ Disease : Market Outlook
11. Graves’ Disease Market Drivers
12. Graves’ DiseaseMarket Barriers
13. Graves’ Disease Market access and Reimbursement
14. SWOT Analysis
15. Graves’ Disease Unmet Needs
16. KOL Views
17. Appendix
18. Disclaimer
19. About DelveInsight

Know more about report offerings @ Graves’ Disease Market Outlook

Related Reports

Graves Ophthalmopathy Market

DelveInsight’s “Graves Ophthalmopathy – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Graves Ophthalmopathy, historical and forecasted epidemiology as well as the Graves Ophthalmopathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Graves Orbitopathy Market

DelveInsight’s “Graves Orbitopathy – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Graves Orbitopathy , historical and forecasted epidemiology as well as the Graves Orbitopathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

High Grade Glioma Market

Get comprehensive historical and forecast analysis of High Grade Glioma Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Genentech, Merck, Orbus Therapeutics, Bayer, MedImmune, Aivita Biomedical, among others.

Granulomatosis With Polyangiitis Market

Get comprehensive historical and forecast analysis of Granulomatosis With Polyangiitis Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Genentech, Biogen Idec, GlaxoSmithKline, Bristol-Myers Squibb, among others.

Low-Grade Upper Tract Urothelial Cancer Market

DelveInsight’s “Low-Grade Upper Tract Urothelial Cancer (LG UTUC) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Low-Grade Upper Tract Urothelial Cancer (LG UTUC) , historical and forecasted epidemiology as well as the Low-Grade Upper Tract Urothelial Cancer (LG UTUC) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Dravet Syndrome Market 

Get comprehensive historical and forecast analysis of Dravet Syndrome Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Biocodex, GW Pharmaceuticals, Zogenix, Ovid Therapeutics, PTC Therapeutics, among others.

Alzheimer’s Disease Market

DelveInsight’s “Alzheimer’s Disease Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Alzheimer’s Disease, historical and forecasted epidemiology as well as the Alzheimer’s disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Parkinson’s Disease Market

DelveInsight’s “Parkinson’s Disease – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Parkinson’s Disease, historical and forecasted epidemiology as well as the Parkinson’s Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Adult-Onset Still’s Disease Market

Get comprehensive historical and forecast analysis of Adult-Onset Still’s Disease Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Novartis, Swedish Orphan Biovitrum, Roche, Cerecor, AB2 Bio Ltd, among others.

Celiac Disease Market

Get comprehensive historical and forecast analysis of Celiac Disease Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as 9 Meters Biopharma, ImmunogenX, Provention Bio, Takeda/Cour Pharmaceuticals, Precigen ActoBio, Falk Pharma and Zedira, among others.

For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare and Biotech Blog Posts

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance. 

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Us 

Sandeep Joshi 

[email protected] 

+1(919)321-6187 

www.delveinsight.com

Connect With Us at:

LinkedIn | Facebook | Twitter

Tags: Graves' Disease Treatment Guidelines, Graves' Disease Drugs, Graves’ Disease, Graves’ Disease market, Graves' Disease Symptoms, Treatment for Graves' Disease, Graves' Disease ICD 10, Graves' Disease Causes, Graves' Disease Companies

Contact Information:

Sandeep Joshi 

[email protected] 

+1(919)321-6187

Add Comment

Click here to post a comment

Your email address will not be published. Required fields are marked *